Study of Celecoxib Bioavailability in Healthy Subjects
Completed · Phase 1
Conditions studied: Healthy Volunteers
In brief
To evaluate the bioavailability of celecoxib administered as capsule contents sprinkled onto applesauce relative to intact capsule
Key facts
- Study ID
- NCT00296127
- Run by
- Pfizer's Upjohn has merged with Mylan to form Viatris Inc.
- People needed
- 24
- Starts
- 2006-02-01
- Expected to finish
- 2006-03-01
- Last updated by the study team
- 2021-03-03
Who can join
Age: 18 and older, up to 55. Sex: any. Healthy volunteers: accepted.
You may qualify if…
- Healthy male and/or female subjects
You may not qualify if…
- Standard criteria for healthy volunteer studies
Where it is running
- Pfizer Investigational Site — New Haven, Connecticut, United States
Full record on ClinicalTrials.gov
Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.